As fear mounts over the spread of the mysterious flulike illness known as SARS, the most pressing need in the medical world today is not for a new vaccine or treatment, but for a quick test to detect ...
In England and Scotland, hospitals discontinued universal admission testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections starting August 31, 2022, and September 28, 2022 ...
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...
SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho (QDEL)"), a leading global provider of ...
CARLSBAD, Calif., March 19, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the ...
ATLANTA -- Federal health officials said Thursday they are confident about the accuracy of the main antibody test being used to screen people for SARS. The Centers for Disease Control and Prevention ...
Voluntary SARS CoV 2 testing of the hemodialysis population may require incentives beyond varying test frequency. Only 8% of patients voluntarily comply with repeat SARS-CoV-2 testing in hemodialysis ...
In a recent study posted to the medRxiv* preprint server, researchers promote severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing among underserved communities in rural Alabama, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results